BARICITINIB - A JANUASE KINASE INHIBITOR - NOT AN IDEAL OPTION FOR MANAGEMENT OF COVID 19.

Clicks: 290
ID: 103210
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
praveen2020baricitinibinternational Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Praveen, D;Chowdary, Puvvada Ranadheer;Aanandhi, M Vijey;
Journal international journal of antimicrobial agents
Year 2020
DOI
S0924-8579(20)30124-2
URL
Keywords
diabetes mellitus italy comorbidities covid-19 chronically ill patients

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.